Filing Details
- Accession Number:
- 0001237648-21-000040
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-09 16:20:58
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-09 16:20:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1038133 | Heska Corp | HSKA | In Vitro & In Vivo Diagnostic Substances (2835) | 770192527 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1724324 | Catherine Grassman | 3760 Rocky Mountain Avenue Loveland CO 80538 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-06 | 5,000 | $69.77 | 8,986 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-06 | 4,679 | $260.15 | 4,307 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-06 | 271 | $261.23 | 4,036 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-06 | 50 | $263.25 | 3,986 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-06 | 5,000 | $0.00 | 5,000 | $69.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 701 | 2018-03-07 | 2028-03-06 | No | 4 | M | Direct |
Footnotes
- The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.85. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected.
- The price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.00 to $261.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which each transaction was effected.
Billionaire Hedge Funds
